Change provisions relating to the use of the Hospital Quality Assurance and Access Assessment Fund
LB945 would amend the Hospital Quality Assurance and Access Assessment Act to revise how the Hospital Quality Assurance and Access Assessment Fund is used. The bill keeps the fund in place, credits interest to it, and directs the state investment officer to invest available money under existing state investment laws. It also specifies that the Department of Health and Human Services must use the fund, along with federal matching dollars, to increase Medicaid hospital payment rates, while prohibiting the money from being used to replace or offset existing state hospital funding.
The bill further lays out a series of required uses for the fund: reimbursing the General Fund for the first quarterly payment each fiscal year, paying a capped administrative fee for assessment collection and directed-payment administration, providing support to the Nebraska Center for Nursing for clinical nursing training site expansion, and funding nonhospital provider rates for Medicaid-related programs such as continuous eligibility for children and the designated health information exchange. It also requires that any assessment proceeds and federal match not otherwise used be applied to enhance inpatient and outpatient hospital rates, and it adds data-reporting requirements for hospitals that do not file annual Medicare cost reports.
LB945 also addresses managed care and hospital payment practices. It would prohibit Medicaid managed care organizations from setting or negotiating hospital reimbursement rates in ways that account for directed payments under the act, including delaying, recouping, or offsetting those payments. In addition, hospitals would be barred from passing the cost of the assessment on to patients or non-Medicaid payers through fee or rate increases. A hospital that violates these restrictions would lose eligibility for directed payments for the remainder of the rate year.
The overall sentiment in the available record appears limited but neutral-to-supportive in policy design, since the bill is framed as a technical and funding-structure amendment rather than a major program overhaul. However, the bill was ultimately indefinitely postponed, which suggests it did not advance and may have lacked sufficient support or consensus. No committee transcript or vote record is available in the provided material, so the public debate cannot be directly assessed from the record here.
The main points of contention likely involve how assessment revenue is allocated, whether the bill’s restrictions on managed care organizations and hospitals are workable, and whether the fund’s uses should be broadened beyond hospital rate enhancement. The prohibition on passing assessment costs through to patients or other payers, and the limits on how managed care entities may factor directed payments into negotiations, are the most likely areas of dispute because they directly affect hospital financing and payer contracting.
LB945 would amend the Hospital Quality Assurance and Access Assessment Act and related statutes governing the Hospital Quality Assurance and Access Assessment Fund. It would preserve the assessment-based financing structure, direct fund revenues toward Medicaid hospital rate enhancements and specified administrative and programmatic uses, impose new reporting obligations on certain hospitals, and restrict how managed care organizations and hospitals may account for directed payments and assessment costs. The bill would therefore affect the Department of Health and Human Services, hospitals, Medicaid managed care organizations, the Nebraska Center for Nursing, and other nonhospital providers tied to Medicaid financing.
The available record shows no committee testimony or recorded votes, so there is no direct evidence of public debate in the materials provided. Based on the bill text, the measure appears to be a targeted financing and administration bill intended to support hospital and Medicaid payment structures, but its indefinite postponement indicates it did not secure enough legislative momentum to advance. That outcome suggests at least some level of unresolved concern or lack of consensus.
Likely points of contention include the bill’s allocation of assessment revenue among hospitals, administrative costs, nursing training expansion, and nonhospital provider payments; the prohibition on managed care organizations considering directed payments in rate negotiations; and the ban on hospitals passing assessment costs through to patients or non-Medicaid payers. Hospitals and managed care organizations would be most directly affected by these restrictions, while state agencies and Medicaid stakeholders would be concerned with how the fund is administered and whether the proposed uses align with existing financing priorities.